OS Therapies Incorporated
OSTX
$1.86
$0.031.64%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -11.19% | -11.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.66% | -15.18% | |||
| Operating Income | 15.66% | 15.18% | |||
| Income Before Tax | 16.97% | 22.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.97% | 22.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.97% | 22.76% | |||
| EBIT | 15.66% | 15.18% | |||
| EBITDA | 15.85% | 15.34% | |||
| EPS Basic | 26.86% | 30.42% | |||
| Normalized Basic EPS | 26.85% | 30.43% | |||
| EPS Diluted | 26.86% | 30.42% | |||
| Normalized Diluted EPS | 26.85% | 30.43% | |||
| Average Basic Shares Outstanding | 13.52% | 11.00% | |||
| Average Diluted Shares Outstanding | 13.52% | 11.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||